CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

May 9, 2022 · earnings

NGNE earnings: a negative outcome, -7.3%

On May 9, 2022, Neurogene Inc. reached its earnings. The result was a negative outcome, and the stock moved -7.3% in the window around the event. It had already run -30.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$24.60
1d before
$22.80
Event day
$23.00
1d after
$19.60
5d after

Pre-catalyst setup

-30.9%
30-day run-up
6833%
30-day volatility
0.4×
volume spike